MHRA puts supporting patient access to innovation at the heart of its new Corporate Plan 2023-26
A new, visionary Corporate Plan, setting out how the Medicines and Healthcare products Regulatory Agency plans to keep patients safe by enabling access to innovative, safe and effective medical products over the coming three years, has been published today (4 July 2023).
Read the press release from Medicines and Healthcare products Regulatory Agency published on 4 July 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (4 septembre 2023). MHRA puts supporting patient access to innovation at the heart of its new Corporate Plan 2023-26. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o6d3
